Cambridge researchers have created a ‘metal detector’ algorithm that can hunt down vulnerable tumours, in a development that could one day revolutionise the treatment of cancer.
Cambridge researchers are to lead a £10 million project that could result in doctors being able to predict your individual chances of getting cancer and offer personalised detection and prevention.
Cambridge scientists have developed a urine test for early detection of lung cancer. The test, the first of its kind, detects ‘zombie’ cells that could indicate the first signs of the disease.
A pivotal clinical trial of a 'pill-on-a-thread' test, which will decide if it becomes a new screening programme for oesophageal cancer, has welcomed its first participants.
Cancer Research UK (CRUK) has today announced a £173 million investment in its institute at the University of Cambridge - the largest single grant ever awarded by the charity outside of London.
In 1994, a landmark paper identified a gene – BRCA1 – that significantly increases the risk of breast and ovarian cancers when faulty. Thirty years on, we look at the major impact it has had on how we understand and treat cancer – and why there is still much to learn.
A unique collaboration of astronomers and cancer researchers at Cambridge has been awarded more than £5m to establish the Spatial Profiling and Annotation Centre of Excellence (SPACE) to open up access to their groundbreaking cancer mapping technology and establish collaborations with other scientists to enable them to investigate tumours in 3D.
A new study aims, for the first time, to pinpoint the very moment the immune system recognises a tumour to try to stop the disease earlier than previously possible.
New, repurposed and combined treatments could soon transform prostate cancer outcomes, with DNA repair research informing promising clinical trials at Cambridge.